Cargando…
Experimental and clinical progress of in utero hematopoietic cell transplantation therapy for congenital disorders
In utero hematopoietic cell transplantation (IUHCT) is considered a potentially efficient therapeutic approach with relatively few side effects, compared to adult hematopoietic cell transplantation, for various hematological genetic disorders. The principle of IUHCT has been extensively studied in r...
Autores principales: | Shi, Chunyu, Pan, Lu, Hu, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478511/ https://www.ncbi.nlm.nih.gov/pubmed/36120324 http://dx.doi.org/10.3389/fphar.2022.851375 |
Ejemplares similares
-
In utero hematopoietic cell transplantation for hemoglobinopathies
por: Derderian, S. Christopher, et al.
Publicado: (2015) -
In utero therapy for congenital disorders using amniotic fluid stem cells
por: Ramachandra, Durrgah L., et al.
Publicado: (2014) -
In utero hematopoietic cell transplantation: induction of donor specific immune tolerance and postnatal transplants
por: Peranteau, William H.
Publicado: (2014) -
Corrigendum: In utero therapy for congenital disorders using amniotic fluid stem cells
por: Ramachandra, Durrgah L., et al.
Publicado: (2015) -
NK cell tolerance as the final endorsement of prenatal tolerance after in utero hematopoietic cellular transplantation
por: Alhajjat, Amir M., et al.
Publicado: (2015)